Sign in

Fenbendazole & Liver and biliary tract cancer

Checked 11 Nov 2026 · Liver and biliary tract cancer

AI-generated image

Written based on 3 research studies on PubMed, searched on 11 Nov 2026.

The claim

Posts online say that fenbendazole helps with liver and biliary tract cancer.

Where research stands

We found 3 published papers on fenbendazole and liver and biliary tract cancer. They were published between 1999 and 2022. None of them is a study in people. 2 were studies in animals, and 1 was only in cells in the lab.

  • 0In people
  • 2In animals
  • 1Only in the lab

What the studies found

We have not summed up these studies in words yet. The most important papers are listed under Sources.

Verdict

Unproven

Fenbendazole has been studied for liver and biliary tract cancer in animals, not yet in people.

Unproven means: it was only tested in animals or cells, or there is too little or mixed data from people. How we rate claims

What this means for you: Results in animals or in cells often do not hold in people. Do not stop or change your medicines because of it. Ask your doctor before you start taking it.

Sources

  1. Lack of modification of 2-amino-3,8-dimethylimidazo[4,5-f]quinoxaline (MeIQx)-induced hepatocarcinogenesis in rats by fenbendazole--a CYP1A2 inducer.2002 · Cancer Lett · In animals
  2. Liver tumor promoting effects of fenbendazole in rats.1999 · Toxicol Pathol · In animals
  3. Fenbendazole Suppresses Growth and Induces Apoptosis of Actively Growing H4IIE Hepatocellular Carcinoma Cells via p21-Mediated Cell-Cycle Arrest.2022 · Biol Pharm Bull · In the lab

More checked claims